Blue Water Acquisition IV, a fourth blank check company led by the founder of Blue Water Venture Partners targeting healthcare and tech, raised $125 million by offering 12.5 million units at $10. Blue Water Acquisition IV is led by CEO and Chairman Joseph Hernandez, the founder and Senior Managing Partner of investment firm Blue Water Venture Partners, and the founder of 2022 biotech IPO Blue Water Vaccines (now Onconetix; ONCO). The SPAC plans to target the biotechnology, healthcare, and technology sectors. Particular areas of interest include pharmaceuticals, medical devices, telemedicine, AI/ML, and cloud computing, among others.
Read the full article: Healthcare-Focused SPAC Blue Water Acquisition IV Prices $125M IPO //
Source: https://www.renaissancecapital.com/IPO-Center/News/117779/Healthcare-focused-SPAC-Blue-Water-Acquisition-IV-prices-$125-million-IPO